The company is focused on breathalyzer operations across law enforcement, workplace, corrections, OEM and international markets, and recently discontinued its rental-property segment to focus fully on core operations from its Wheat Ridge, Colorado headquarters. Lifeloc entered into an agreement in October 2025 to acquire Electronic Systems Technology, Inc. for $0.74 million as part of strategic expansion efforts.
Cyborg Score Rationale
Lifeloc operates in a mature, regulated market with established products and steady revenue growth of 6% in 2025. However, the company faces scale constraints as a micro-cap OTC-traded entity with limited financial resources, while investing in new drug-testing platform development signals growth ambition but also execution risk.
Top Insights
(January 2025) Revenue growth of 6% year-over-year to $8.96 million in product sales in 2025 despite challenging small-cap environment
(October 2025) Strategic acquisition of Electronic Systems Technology for $0.74 million to expand product capabilities
(May 2026) Q1 2026 loss reduction achieved while investing in SpinDetect drug-testing platform development with new debt financing
Focused diversification strategy beyond breathalyzers toward multi-substance detection and drug testing to address larger market opportunity
Named Competitors
AlcoBlow — Portable breath alcohol testing
Intoxilyzer — Law enforcement breathalyzer systems
Drager — Drug and alcohol testing equipment
Recent Developments
(March 2026) 2025 annual results reported with 6% revenue growth and advancement of SpinDetect™ drug-testing platform
(October 2025) Acquisition agreement signed for Electronic Systems Technology, Inc. at $0.74 million valuation
(May 2026) Q1 2026 quarterly results showed reduced losses with new debt funding for SpinDetect platform development
Open the full interactive Lifeloc Technologies, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.